The genomic landscape of nasopharyngeal carcinoma
- PMID: 24952746
- DOI: 10.1038/ng.3006
The genomic landscape of nasopharyngeal carcinoma
Abstract
Nasopharyngeal carcinoma (NPC) has extremely skewed ethnic and geographic distributions, is poorly understood at the genetic level and is in need of effective therapeutic approaches. Here we determined the mutational landscape of 128 cases with NPC using whole-exome and targeted deep sequencing, as well as SNP array analysis. These approaches revealed a distinct mutational signature and nine significantly mutated genes, many of which have not been implicated previously in NPC. Notably, integrated analysis showed enrichment of genetic lesions affecting several important cellular processes and pathways, including chromatin modification, ERBB-PI3K signaling and autophagy machinery. Further functional studies suggested the biological relevance of these lesions to the NPC malignant phenotype. In addition, we uncovered a number of new druggable candidates because of their genomic alterations. Together our study provides a molecular basis for a comprehensive understanding of, and exploring new therapies for, NPC.
Comment in
-
Fingerprints of Epstein-Barr virus in nasopharyngeal carcinoma.Nat Genet. 2014 Aug;46(8):809-10. doi: 10.1038/ng.3038. Nat Genet. 2014. PMID: 25070800 No abstract available.
Similar articles
-
Super-Enhancers Promote Transcriptional Dysregulation in Nasopharyngeal Carcinoma.Cancer Res. 2017 Dec 1;77(23):6614-6626. doi: 10.1158/0008-5472.CAN-17-1143. Epub 2017 Sep 26. Cancer Res. 2017. PMID: 28951465 Free PMC article.
-
Whole-exome sequencing identifies multiple loss-of-function mutations of NF-κB pathway regulators in nasopharyngeal carcinoma.Proc Natl Acad Sci U S A. 2016 Oct 4;113(40):11283-11288. doi: 10.1073/pnas.1607606113. Epub 2016 Sep 19. Proc Natl Acad Sci U S A. 2016. PMID: 27647909 Free PMC article.
-
Pre-treatment with angiotensin-(1-7) inhibits tumor growth via autophagy by downregulating PI3K/Akt/mTOR signaling in human nasopharyngeal carcinoma xenografts.J Mol Med (Berl). 2018 Dec;96(12):1407-1418. doi: 10.1007/s00109-018-1704-z. Epub 2018 Oct 29. J Mol Med (Berl). 2018. PMID: 30374682 Free PMC article.
-
Translational genomics of nasopharyngeal cancer.Semin Cancer Biol. 2020 Apr;61:84-100. doi: 10.1016/j.semcancer.2019.09.006. Epub 2019 Sep 12. Semin Cancer Biol. 2020. PMID: 31521748 Review.
-
Genetic and epigenetic landscape of nasopharyngeal carcinoma.Chin Clin Oncol. 2016 Apr;5(2):16. doi: 10.21037/cco.2016.03.06. Chin Clin Oncol. 2016. PMID: 27121876 Review.
Cited by
-
Harmonization of postmortem donations for pediatric brain tumors and molecular characterization of diffuse midline gliomas.Sci Rep. 2020 Jul 2;10(1):10954. doi: 10.1038/s41598-020-67764-2. Sci Rep. 2020. PMID: 32616776 Free PMC article.
-
High expression of Sox10 correlates with tumor aggressiveness and poor prognosis in human nasopharyngeal carcinoma.Onco Targets Ther. 2016 Mar 21;9:1671-7. doi: 10.2147/OTT.S101344. eCollection 2016. Onco Targets Ther. 2016. PMID: 27051302 Free PMC article.
-
Amyloid aggregates induced by the p53-R280T mutation lead to loss of p53 function in nasopharyngeal carcinoma.Cell Death Dis. 2024 Jan 11;15(1):35. doi: 10.1038/s41419-024-06429-8. Cell Death Dis. 2024. PMID: 38212344 Free PMC article.
-
The Hunt for the perfect biomarker in nasopharyngeal carcinoma-the RRAS "race" beyond Epstein-Barr virus?Transl Cancer Res. 2019 Sep;8(5):1659-1662. doi: 10.21037/tcr.2019.08.02. Transl Cancer Res. 2019. PMID: 35116914 Free PMC article. No abstract available.
-
BRD7 inhibits enhancer activity and expression of BIRC2 to suppress tumor growth and metastasis in nasopharyngeal carcinoma.Cell Death Dis. 2023 Feb 14;14(2):121. doi: 10.1038/s41419-023-05632-3. Cell Death Dis. 2023. PMID: 36788209 Free PMC article.
References
Publication types
MeSH terms
Substances
Associated data
- Actions
- SRA/SRP035573
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Research Materials
Miscellaneous